Tmunity Therapeutics

Usman Azam, M.D., President and CEO
Philadelphia, PA
Tmunity Therapeutics is a private clinical stage biotherapeutics company delivering the potential of next-generation T-cell immunotherapies in cancer. Tmunity integrates collaborations with the University of Pennsylvania with groundbreaking scientific, clinical, manufacturing expertise and a demonstrated track record of its founders and management. The company is developing a diversified portfolio of novel treatments that exhibit best-in-class control over T-cell activation and direction in the body. These personalized immunotherapies are advancing rapidly in the clinic. With headquarters in Philadelphia, Tmunity also has a dedicated cGMP manufacturing facility in Norristown, PA. Tmunity has raised 243 million dollars since inception and has 75 employees.

By using this website you agree to accept our Privacy Policy and Terms & Conditions